This supplement to The American Journal of Managed Care reviews the clinical benefits of in vitro allergy testing for physicians, patients, and payers. It describes the numerous challenges to the diagnosis and management of allergic diseases in the primary care setting, and discusses the value of specific immunoglobulin E testing. This supplement also reviews the economic burden of asthma and allergic disease, and discusses management strategies to reduce costs and improve patient outcomes.
Faculty
Jacqueline S. Eghrari-Sabet, MD
Medical Director and Founder
Family Allergy & Asthma Care
Gaithersburg, Maryland
Ryan Horn, CPC, CCS-P
Lead Revenue Cycle Analyst
Bronson Healthcare Group
Kalamazoo, Michigan
Kenny Y.C. Kwong, MD
Chief, Division of Allergy-Immunology
Associate Professor of Pediatrics
Department of Pediatrics
Harbor-UCLA Medical Center
Torrance, California
Guillermo R. Mendoza, MD
Department of Allergy
Kaiser Permanente
Vacaville Medical Center
Vacaville, California
Thomas Platts-Mills, MD, PhD
Head, Division of Asthma, Allergy, and Immunology
University of Virginia
UVA Asthma & Allergic Diseases Center
Charlottesville, Virginia
Faculty Disclosures
These faculty report relationships with the following organizations:
Jacqueline S. Eghrari-Sabet, MD
Advisory board: Phadia Diagnostics
Honoraria: Phadia Diagnostics
Kenny Y.C. Kwong, MD
Consultant/advisory board: Phadia Diagnostics
Grants: Phadia Diagnostics
Thomas Platts-Mills, MD, PhD
Consultant/advisory board: Viracor-IBT Laboratories
Grants: Phadia Diagnostics
Ryan Horn, CPC, CCS-P; and Guillermo R. Mendoza, MD, have nothing to disclose.
The American Journal of Managed Care
Signed disclosures are on file at the office of , Plainsboro, New Jersey.
Thermo Fisher Scientific
This supplement was supported by Phadia, now .
Preparation of this supplement was underwritten by an educational grant from Phadia US Inc, now Thermo Fisher Scientific, Portage, Michigan.